Abstract
The etiology and pathogenesis of Crohn's disease, a chronic inflammatory bowel pathology, have not been elucidated yet. In particular, the behavior of peroxisomes in inflamed colonic mucosa has not been investigated despite their important role in cellular oxidative metabolism. Using cytochemistry at the ultrastructural level, we have observed these catalase-positive organelles. In addition, biochemical analyses have revealed the specific activities of catalase and cyanide-insensitive acyl-CoA oxidase. Mucosal biopsy specimens from inflamed and noninflamed areas of Crohn's patients were compared to control biopsies. We found that Crohn's disease was marked by an important diminution in the peroxisomal frequency per cell unit area. If catalase activity was not affected by this pathology, cyanide-insensitive acyl-CoA oxidase, an enzyme of the peroxisomal β-oxidation system, was found diminished in inflamed and in noninflamed areas. In conclusion, our results showed that Crohn's disease is accompanied by peroxisomal modifications but the number and the enzyme activities of colonic peroxisomes are less deeply altered in Crohn's disease than during neoplasia. This fact suggests that a relation may exist between the degree of peroxisomal deficiency and the clinical severity of colonic disease.
Similar content being viewed by others
References
Crohn BB, Ginzburg L, Oppenheimer GD: Regional ileitis: A pathological and clinical entity. JAMA 99:1323–1329, 1932
Stenson WF: Pathogenesis of inflammatory bowel disease.In The year in Immunology 1984–85. Basel, Karger, 1985, pp 214–218
Kirsner JB, Shorter RG: Recent developments in nonspecific inflammatory bowel disease. 1. N Engl J Med 306:775–785, 1982
Kirsner JB, Shorter RG: Recent developments in nonspecific inflammatory bowel disease. 2. N Engl J Med 306:837–848, 1982
Jewell DP, Patel C: Immunology of inflammatory bowel disease. Scand J Gastroenterol 20(suppl 114):119–126, 1985
Verspaget HW, Mieremet-Ooms MAC, Weterman IT, Peña AS: Partial defect of neutrophil oxidative metabolism in Crohn's disease. Gut 25:849–853, 1984
Curran FT, Allan RN, Keighley MRB: Superoxide production by Crohn's disease neutrophils. Gut 32:399–402, 1991
de Duve C, Baudhuin P: Peroxisomes (microbodies and related particles). Physiol Rev 46:323–357, 1966
Cablé S, Keller JM, Colin S, Haffen K, Kédinger M, Parache RM, Dauça M. Peroxisomes in human colon carcinomas. A cytochemical and biochemical study. Virchows Arch B Cell Pathol 62:221–226, 1992
Ginzburg L, Schneider KM, Dreizin DH, Levinson C: Carcinoma of the jejunum occurring in a case of regional enteritis. Surgery 39:347–351, 1956
Hoffman JP, Taft DA, Wheelis RF, Walker JH: Adenocarcinoma in regional enteritis of the small intestine. Arch Surg 112:606–611, 1977
Greenstein AJ, Sachar DB, Smith H, et al: A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer 48:2742–2745, 1981
Fresko D, Lazarus SS, Dotan J, Reingold M: Early presentation of carcinoma of the small bowel in Crohn's disease (Crohn's carcinoma). Gastroenterology 82:783–789, 1982
Korelitz B: Carcinoma of the intestinal tract in Crohn's disease: Results of a survey conducted by the National Foundation for Ileitis and Colitis. Am J Gastroenterol 78:44–46, 1983
Senay E, Sachar DB, Keohane M, Greenstein AJ: Small bowel carcinoma in Crohn's disease: Distinguishing features and risk factors. Cancer 63:360–363, 1989
Richards ME, Rickert RR, Nance FC: Crohn's disease-associated carcinoma: A poorly recognized complication of inflammatory bowel disease. Ann Surg 209:764–773, 1989
Cuvelier C, Bekaert E, De Potter C, et al: Crohn's disease with adenocarcinoma and dysplasia: Macroscopical, histological and immunohistochemical aspects of two cases. Am J Pathol 13:187–196, 1983
Savoca PE, Ballantyne GH, Cahow CE: Gastro-intestinal malignancies in Crohn's disease: A 20-year experience. Dis Colon Rectum 33:7–11, 1990
Ribeiro MB, Greenstein AJ, Heimann TM, Yamazaki Y, Aufses AH: Adenocarcinoma of the small intestine in Crohn's disease. Surgery 173:343–349, 1991
Van Hees PAM, Van Elteren PH, Van Lier HJJ, Van Tongeren JHM: An index of inflammatory activity in patients with Crohn's disease. Gut 21:279–286, 1980
Harvey RF, Bradshow JM: A simple index of Crohn's disease activity. Lancet 1:514, 1980
Novikoff AB, Novikoff PM, Davis C, Quintana N: Studies on microperoxisomes. II. A cytochemical method for light and electron microscopy. J Histochem Cytochem 20:1006–1023, 1972
Reynolds ES: The use of lead citrate at hight pH as an electron-opaque stain in electron microscopy. J Cell Biol 17:208–212, 1963
Weibel ER: Stereological principles for morphometry in electron microscopy cytology. Int Rev Cytol 26:235–302, 1969
Sun AS, Sepkowitz K, Geller SA: A study of some mitochondrial and peroxisomal enzymes in human colonic adenocarcinoma. Lab Invest 44:13–17, 1981
Baudhuin P, Beaufay H, Rahman-Li Y, Sellinger OZ, Wattiaux R, Jacques P, de Duve C: Tissue fractionation studies—17—Intracellular distribution of monoaminotransferase,d-amino acid oxidase and catalase in rat liver tissue. Biochem J 92:179–184, 1964
Hryb DJ, Hogg JF: Chain length specificities of peroxisomal and mitochondrial β-oxidation in rat liver. Biochem Biophys Res Commun 87:1200–1206, 1979
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin-phenol reagent. J Biol Chem 193:265–275, 1951
Roels F, Espeel M, De Craemer D, Egberts HJA, Van der Spek P: Different types of peroxisomes in human duodenal epithelium. Gut 32:858–865, 1991
Masters CJ: On the turnover and multiplicity of the peroxisomal catalases. Ann NY Acad Sci 383:301–313, 1982
Fukami MH, Flatmark T: Studies on catalase compartimentation in digitonin-treated rat hepatocytes. Biochem Biophys Acta 889:91–94, 1986
Geerts A, de Prest B, Roels F: On the topology of the catalase biosynthesis and degradation in the guinea pig liver. A cytochemical study. Histochemistry 80:339–345, 1984
Hemsley A, Pegg M, Crane D, Masters C: On the compartmentalization of catalase, fatty acyl-CoA oxidase and urate oxidase in mammalian livers, and the influence of clofibrate treatment on this microlocalization. Mol Cell Biochem 83:187–194, 1958
O'Morain C, Smethurst P, Levi AJ, Peters TJ: Organelle pathology in ulcerative and Crohn's colitis with special reference to the lysosomal alterations. Gut 25:455–459, 1984
O'Morain C, Smethurst I, Levi AJ, Peters TJ: Subcellular fractionation of rectal biopsy homogenates from patients with inflammatory bowel disease. Scand J Gastroenterol 20:209–214, 1985
Alexson SEH, Cannon B: A direct comparison between peroxisomal and mitochondrial preferences for fatty-acyl β-oxidation predicts channeling of medium-chain and very-long-chain unsaturated fatty acids to peroxisomes. Biochem Biophys Acta 796:1–10, 1984
Dunne WT, Cooke WT, Allan RN: Enzymatic and morphometric evidence for Crohn's disease as a diffuse lesion of the gastrointestinal tract. Gut 18:290–294, 1977
Rickert RR, Carter HW: The “early” ulcerative lesion of Crohn's disease: Correlative light- and scanning electron-microscopic studies. J Clin Gastroenterol 2:11–19, 1980
Dourmashkin RR, Davies H, Wells C, Shah D, Price A, O'Morain C, Levi J: Epithelial patchy necrosis in Crohn's disease. Hum Pathol 14:643–648, 1983
Makiyama K, Bennet MK, Jewell DP: Endoscopic appearances of the rectal mucosa of patients with Crohn's disease visualized with a magnifying colonoscope. Gut 25:337–340, 1984
Diczfalusy U, Alexson SEH, Pedersen JI: Chain-shortening of prostaglandin F2α by rat liver peroxisomes. Biochim Biophys Res Commun 144:1206–1213, 1987
Diczfalusy U, Alexson SEH: Peroxisomal chain-shortening of prostaglandin F2α. J Lipid Res 29:1629–1636, 1988
Schepers L, Casteels M, Vamecq J, Parmentier G, Van Veldhoven PP, Mannaerts GP: β-Oxidation of the carboxyl side chain of prostaglandin E2 in rat liver peroxisomes and mitochondria. J Biol Chem 263:2724–2731, 1988
Sharon P, Ligumsky M, Rachmilewitz D, Zor V: Role of prostoglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology 75:638–640, 1978
Donowitz M: Arachidonic acid metabolites and their role in inflammatory bowel disease. An update requiring addition of a pathway. Gastroenterology 88:580–587, 1985
Rampton DS, Hawkey CJ: Prostaglandins and ulcerative colitis. Gut 25:1399–1413, 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aimone-Gastin, I., Cable, S., Keller, J.M. et al. Studies on peroxisomes of colonic mucosa in Crohn's disease. Digest Dis Sci 39, 2177–2185 (1994). https://doi.org/10.1007/BF02090368
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02090368